fbpx

< Back to Thought Leadership

Change to the Indiana Medicaid Home Health Cost Report

Effective January 20, 2019, the process for calculating Indiana Medicaid reimbursement rates for home health services has been repealed. In addition, the requirement to file the Indiana Medicaid home health agency cost report is no longer effective. These changes were made to Indiana Administrative code 405 IAC 1-4.2. Therefore, no Indiana Medicaid home health cost reports will need to be filed beyond January 20, 2019.

Because of these changes, a revision to the calculation of the statewide Medicaid reimbursement rates is currently being determined. The current rates from July 1, 2018 through June 30, 2019 can be found on the Indiana Health Coverage Programs (IHCP) Bulletin BT201826. These rates will remain effective until further notice.

In place of the cost report, the Office of Medicaid Policy and Planning (OMPP) has approved a new cost survey. This cost survey will only be allowed to be filed once and the information provided will be used to set new Medicaid home health reimbursement rates for all future years. The due date for the cost survey is April 30, 2019.

It is extremely important to understand how the information filed on the cost survey can impact Medicaid reimbursement rates in the future. If you need assistance filing the new cost survey or if you have any questions, please contact Kyle Smith at kcsmith@blueandco.com.

 

heart and a jar of money

Unveiling the Dynamics of Donor-Restricted Contributions

By Greg Jackson, CPA, Principal at Blue & Co. Many not-for-profit organizations rely on public support (grants and contributions) to finance their mission. When that public support includes donor-restricted grants and contributions, those restricted amounts must be reported and accounted for in accordance with the related restrictions attached to the funds. When recording a donor-restricted […]

Learn More

How to Manage Clinical Validation Denials

In the past several years, hospitals have continued to feel the impact on revenue from Clinical Validation Denials (CVD). The need for a robust CDI team to capture support for clinical indicators while the patient is still in house is more imperative than ever. The other overwhelming piece for revenue cycle teams to manage is […]

Learn More

Margin Improvement: Optimizing Financial Performance

Ensuring the long-term financial viability of a health system requires constant attention to the operating statement. This involves assessing the current state of your healthcare organization and critically comparing the current condition to industry and/or internal benchmark standards. Ultimately, this assessment assists management implement an ongoing margin improvement process to increase the likelihood of achieving […]

Learn More